Latest News and Press Releases
Want to stay updated on the latest news?
-
EnteroBiotix Announces Positive Topline Phase 2a Results with EBX-102-02, a Potential First-in-Class Treatment for Irritable Bowel Syndrome (IBS) EBX-102-02 demonstrated clinically meaningful...
-
Boralex's plans for a new wind farm in a remote Scottish Highland community have been raised in a Scottish Parliament debate.
-
LONDON, Jan. 08, 2025 (GLOBE NEWSWIRE) -- Copenhagen Infrastructure Partners (CIP) has, through its flagship fund CI IV, taken Financial Investment Decision (FID) and issued Notice to Proceed (NTP)...
-
EnteroBiotix Completes Phase 2 Study Recruitment of EBX-102-02 in Irritable Bowel Syndrome 122 patients with moderate to severe irritable bowel syndrome (IBS) were recruited to EnteroBiotix’s Phase...
-
Trogenix Unveils Revolutionary Platform to Transform Cancer Treatment Through Precision Viral Immunotherapy Company founded by 4BIO Capital and Professor Steve Pollard as a spinout from the...
-
EnteroBiotix Completes Phase 2 Study Recruitment of EBX-102-02 in Irritable Bowel Syndrome 122 patients with moderate to severe irritable bowel syndrome (IBS) were recruited to EnteroBiotix’s Phase...
-
Trogenix Unveils Revolutionary Platform to Transform Cancer Treatment Through Precision Viral Immunotherapy Company founded by 4BIO Capital and Professor Steve Pollard as a spinout from the...
-
EBX-102 demonstrated proof-of-principle across multiple microbiome assessments, inflammatory biomarkers and clinical assessments, supporting its continued development as the first microbial therapy...
-
Edinburgh, UK, June 12, 2024 (GLOBE NEWSWIRE) -- AEG Europe, a global leader in live sport and entertainment, has received approved planning permission for a new state-of-the-art 8,500-capacity...
-
Boyden has acquired FWB's Energy Practice in Scotland, UK, further expanding the global organization's presence in the energy sector.